Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, 37# Guo Xue Xiang, Chengdu, Sichuan, 610041, China.
Sci Rep. 2019 May 10;9(1):7257. doi: 10.1038/s41598-019-43659-9.
Small intestinal gastrointestinal stromal tumors (GISTs) have different clinical outcomes when KIT mutations are in exons 11 or 9, which are also the most common sites of neoplastic KIT mutations. The purpose of this study is to evaluate the CT imaging features in those two groups. A total of 35 patients were enrolled, and both quantitative and qualitative CT imaging features were compared between patient groups with KIT exon 9 mutations (KIT-9) and exon 11 mutations (KIT-11). The KIT-9 group was statistically associated with a tumor size larger than 10 cm and a higher enhancement ratio when compared with those of the KIT-11 group (both P < 0.05). For the enhancement ratio, the receiver operating characteristic curve indicated a cut-off value of 1.60 to differentiate KIT-9 from KIT-11 tumors. Additionally, tumor necrosis was more commonly seen in the KIT-9 group. In multivariate analysis, tumor size (β = 0.206; P = 0.022) and KIT-9 (β = 0.389; P = 0.006) were independent factors associated with tumor necrosis. Taken together, KIT-9 mutant tumors tended to have CT imaging features indicative of more aggressive neoplasms. These findings may be helpful in identifying more aggressive small intestinal GISTs and optimizing treatment.
小肠胃肠道间质瘤(GIST)在 KIT 突变位于外显子 11 或 9 时具有不同的临床结局,这也是肿瘤性 KIT 突变的最常见部位。本研究旨在评估这两组患者的 CT 成像特征。共纳入 35 例患者,比较了 KIT 外显子 9 突变(KIT-9)和外显子 11 突变(KIT-11)患者组之间的定量和定性 CT 成像特征。与 KIT-11 组相比,KIT-9 组的肿瘤大小大于 10cm 和增强比值更高,差异具有统计学意义(均 P<0.05)。对于增强比值,ROC 曲线表明,区分 KIT-9 和 KIT-11 肿瘤的截断值为 1.60。此外,KIT-9 组更常见肿瘤坏死。多因素分析表明,肿瘤大小(β=0.206;P=0.022)和 KIT-9(β=0.389;P=0.006)是与肿瘤坏死相关的独立因素。总之,KIT-9 突变型肿瘤往往具有提示侵袭性更强的肿瘤的 CT 成像特征。这些发现可能有助于识别更具侵袭性的小肠 GIST 并优化治疗。